Добірка наукової літератури з теми "Économie de la santé – Cancer – France"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Économie de la santé – Cancer – France".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Économie de la santé – Cancer – France"
Bacon, Marie-Hélène, Louise Vandelac, and Sébastien Petrie. "Pesticides: Le Talon d’Achille des politiques alimentaires canadiennes et québécoises." Canadian Food Studies / La Revue canadienne des études sur l'alimentation 5, no. 3 (September 30, 2018): 153–81. http://dx.doi.org/10.15353/cfs-rcea.v5i3.274.
Повний текст джерелаZimmer, Benjamin. "Enjeux et opportunités de la filière Silver économie : exemple de la France." Angewandte GERONTOLOGIE Appliquée 1, no. 1 (January 2016): 41–42. http://dx.doi.org/10.1024/2297-5160/a000030.
Повний текст джерелаGeeraert, Jérémy. "La prise en charge par l’hôpital des populations à la marge du système de santé en France : l’exemple des Permanences d’accès aux soins de santé." Saúde e Sociedade 27, no. 3 (September 2018): 654–69. http://dx.doi.org/10.1590/s0104-12902018180550.
Повний текст джерелаCharif, A. Ben, A. D. Bouhnik, D. Rey, and J. Mancini. "Santé sexuelle des survivants de cancer en France en 2012." Revue d'Épidémiologie et de Santé Publique 62 (September 2014): S213. http://dx.doi.org/10.1016/j.respe.2014.06.135.
Повний текст джерелаDemeulemeester, R., N. Savy, P. Grosclaude, M. Mounié, N. Costa, and P. Saint-Pierre. "P072 - Modélisation à base d'agent en économie de la santé: exemple dans le champ du cancer thyroïdien." Revue d'Épidémiologie et de Santé Publique 71 (May 2023): 101715. http://dx.doi.org/10.1016/j.respe.2023.101715.
Повний текст джерелаDib, Fadia, Gwenn Menvielle, and Pierre Chauvin. "Tous égaux face aux papillomavirus ? L’infection et la vaccination HPV au prisme des inégalités sociales de santé." Questions de santé publique, no. 38 (November 2019): 1–8. http://dx.doi.org/10.1051/qsp/2019038.
Повний текст джерелаRosenbaum, Jean, Nicolas Bourdel, Saadi Khochbin, Marina Kvaskoff, Sachiko Matsuzaki, Fatima Mechta-Grigoriou, Nicola Pluchino, Olivier Sandra, and Daniel Vaiman. "Des pistes de réflexion pour la recherche sur l’endométriose en France." médecine/sciences 38, no. 3 (March 2022): 274–79. http://dx.doi.org/10.1051/medsci/2022027.
Повний текст джерелаPIERONNE, P., I. RAGUÉNÈS, S. HERCULE-BOBROFF, B. HERSANT, O. LE GOALLEC, and J. F. LORET. "Recyclage des effluents de lavage de filtration au sein d’une filière de production d’eau potable : un guide professionnel pour faciliter les projets." Techniques Sciences Méthodes 1-2 (February 20, 2023): 51–63. http://dx.doi.org/10.36904/202301051.
Повний текст джерелаFassier, P., L. Zelek, P. Bachmann, M. Touillaud, N. Druesne-Pecollo, V. Partula, S. Hercberg, et al. "Déterminants de la prise de poids après diagnostic de cancer dans la cohorte prospective NutriNet-Santé (France)." Revue d'Épidémiologie et de Santé Publique 64 (September 2016): S182—S183. http://dx.doi.org/10.1016/j.respe.2016.06.030.
Повний текст джерелаPouchieu, Camille, Philippine Fassier, Nathalie Druesne-Pecollo, Laurent Zelek, Patrick Bachmann, Marina Touillaud, Isabelle Bairati, et al. "Dietary supplement use among cancer survivors of the NutriNet-Santé cohort study." British Journal of Nutrition 113, no. 8 (March 31, 2015): 1319–29. http://dx.doi.org/10.1017/s0007114515000239.
Повний текст джерелаДисертації з теми "Économie de la santé – Cancer – France"
Bejarano, Quisoboni Daniel. "Economic burden of the long-term effects of treatments for childhood cancer." Electronic Thesis or Diss., université Paris-Saclay, 2023. http://www.theses.fr/2023UPASR010.
Повний текст джерелаChildhood cancer survivors (CCS) may require lifelong medical care due to the late effects of cancer treatments. However, little is known about their healthcare utilization and expenditures at long-term, especially in publicly funded health care system. This thesis aimed to estimate and analyse the long-term health care expenditures and hospitalisation rates among CCS in France and to study their associated factors.The research presented in this thesis was based on data from the French Childhood Cancer Survivors Study (FCCSS), which is a retrospective cohort of 7,670 5-year CCS diagnosed before the age of 21 years between 1946 and 2000 in France. The FCCSS is linked to the National Health Data System (SNDS), which contains comprehensive data on billing and reimbursement of the beneficiaries' health care expenditures since 2006.We found that the annual mean healthcare expenditures among CCS was € 4,255 (SD: 18,790). Expenditures on hospitalization and pharmacy represented ~60% of total expenditures. Our results also showed that female gender and being survivor of a central nervous system (CNS) tumour were associated with increased health care expenditures. We then estimated hospitalisation rates among CCS and detailed the hospitalisation-related clinical diagnoses compared with those of the French general population with the same gender, age and region of residence. We found that survivors were hospitalised more than twice as often as the matched reference population and they had more than three times as many in-patient bed-days. Our results showed that the highest risk for hospitalisation in CCS was related to neoplasm, followed by endocrine diseases, blood diseases, and diseases of the circulatory system. Finally, we compared the health care expenditures of the FCCSS with that of the general French population mentioned above and found that the annual mean excess healthcare expenditures for CCS compared with the median of the reference population was € 3,920 (95% CI: 3539 - 4301). A higher excess was significantly associated with having been treated before the 1990s and having survived a CNS tumour, whereas a lower excess was associated with not receiving treatment with radiotherapy.In conclusion, this thesis showed that CCS are at higher risk of health care use and expenditure, leading to considerable excess compared with the median health care expenditure of the general population of the same sex and age. This high expenditure was related to high hospitalisation rates among CCS. Older survivors, CNS tumours survivors, and those treated with radiotherapy had a higher risk of health service use and expenditure. These results led us to recommend that special attention be paid to this population, especially in terms of follow-up and prevention of complications, and to support the development of effective innovative treatments
Bien, Franck. "Essais en économie de la santé et assurance." Paris 10, 2001. http://www.theses.fr/2001PA100196.
Повний текст джерелаThe purpose of this PhD is to study agency relationship in health economics. We consider three actors: patient, doctor and regulatory-insurance in two frameworks: "French ambulatory medicine" and "health insurance". The first two chapters aim at analysing the fees in "French ambulatory medicine". Medical service is a credence good because the patient does not observe result but only action. We establish doctors are opportunist because they build their reputation on affering best quality and after the supply bad quality. The regulation of free fees of ambulatory medicine is based on doctors' opportunist actions. We can show that the properties of contracts depend on the number of honest doctors and the value of information's regulatory. The last chapters examine "health insurance". .
Pichetti, Sylvain. "La concurrence par comparaison, applications en économie de la santé." Besançon, 2002. http://www.theses.fr/2002BESA0001.
Повний текст джерелаYardstick competition is a way of regulating several regional monopolies so as to induce a form of competition that weakens individual firms' monopolies of information and hence improves the terms of the trade-off between allocative, productive and distributional efficiency. This is done by making the reward to one firm depend on its performance relative to that of other firms. This promising mechanism is however rarely applied in economics. This phenomenon can be explained by the fact that it is difficult to compare firms whose environments are heterogeneous. The DEA method is very convenient to treat this problem. The important potential of the method as a way of comparison is illustrated by two original contributions centered on health economics. The first one aims at estimating the efficiency of hospitals in order to assign to each of them a budget target. The second one aims at estimating the efficiency of health expenses at the departmental level through the DEA method
Sicsic, Jonathan. "Impacts des incitatifs économiques en médecine générale : Analyse des préférences et des motivations des médecins." Thesis, Paris 9, 2014. http://www.theses.fr/2014PA090044/document.
Повний текст джерелаThis thesis addresses several issues raised by the introduction in France of economic incentives such as pay-For-Performance applied to general practice. These incentive schemes are designed to improve the quality of care, but they are discussed both in terms of effectiveness and potential side effects. Initially, we assess the impact of the CAPI scheme on various indicators of quality of care: the consultation length and cancers screening. Then, using the discrete choice experiment methodology, we reveal general practitioners (GPs) preferences for devices aimed at improving the early detection of cancers. Finally, we analyse empirically the relationship between French GPs' intrinsic and extrinsic motivations. We show that the CAPI has not had a significant impact on the selected quality indicators. In addition, GPs would be sensitive to potentially less costly nonmonetary devices. Eventually, we highlight a negative relationship between GPs' intrinsic and extrinsic motivations. Our results call for greater caution in the definition of economic incentives in general practice
Garrouste, Clémentine. "Naître et mourir en France : quatre essais en économie de la santé." Paris, EHESS, 2012. http://www.theses.fr/2012EHES0173.
Повний текст джерелаThis dissertation presents four essays related to health economics. On the one hand, we estimate the effect of activity on health and mortality, by analyzing pensions refom in France. On the other hand, we analyze the choices related to the prenatal diagnosis of Down syndrome (amniocentesis). The first essay shows that retirement has positive effects on mental and social health of seniors. The more physically impacted are the low-educated individuals. Conversly, the high-educated people are more impacted in tenus of social health. The second essay complete the first by evaluating the effect of retirement on mortality. We find that delaying the retirement age by one year increases the chances of dying within four years by 1. 5 percentage points which is equivalent to a decrease of life expectaney by 1. 68 months at age 64. This effect is heterogeneous by income groups. The third essay shows that eligibility to rembursement of amniocentesis has a largely positive effect on the probability of taking an amniocentesis test. By contrast, the sole fact of being labelled 'high-risk' by the Health system seems to have, as such, only a modest effect on subsequent choices. Building or available information on post-amniocentesis outcomes, we report new evidence suggesting that aminoocentesis increases the risk of premature birth and low weight at birth. The last essay completes the third olle by considering the trade off in amniocentesis decision to buil a decision model for pregnant women (amniocentesis requires comparing the risk of giving birth to an affected child and the risk of losing an unaffected child through amniocentesis-related miscarriage)
Mazamba, Tédie. "Éducation, santé et croissance économique." Paris 2, 2005. http://www.theses.fr/2005PA020039.
Повний текст джерелаSeguret, Fabienne. "Le dépistage du cancer du sein dans l'Hérault : méthodes d'évaluation médico-économique et analyse des résultats après 18 mois de réalisation." Montpellier 1, 1992. http://www.theses.fr/1992MON11134.
Повний текст джерелаMeynet, Robert. "Micro-économie de l'infection nosocomiale." Lyon 3, 1987. http://www.theses.fr/1987LYO33020.
Повний текст джерелаThis work has been realized in lyon which is the second largest hospital structure in france in two departments of abdominal surgery for one year and in prospective. 15,4 per cent of the sick have been infected and the cost of this infection amounts to 16. 994 french francs on average per patient 1978, that is an 80 per cent rate of increase (37. 138 20. 144) for infected sick patients as compared with non infected ones. The microeconomic infection cost includes not only invoiced postoperative hospital cost (stay, examinations, medical treatment) but also the post hospital cost, valued from the studied medical consumption angle during the six months after coming out of hospital (new hospital admissions, care, examinations, pharmacy, convalescence home). Another type of non invoiced post operative medical hospital cost valued from a difference in intensity of care between infected sick patients and non infected sick ones : this type of cost comes in addition to invoiced cost. The invoiced social cost worked out from wages paid completes the microeconomical infection cost notion. In relation to previously published international studies, this work presents a particularity in the approach of invoiced medical postoperative hospital cost and non invoiced medical postoperative cost
Sainty, François. "Mutuelles de santé et nouveaux contextes d'action : une approche par le modèle Ressources Compétences." Nice, 2001. http://www.theses.fr/2001NICE0030.
Повний текст джерелаBatifoulier, Philippe. "Incitations et conventions dans l'allocation des ressources : une application à l'économie de la santé." Paris 10, 1991. http://www.theses.fr/1991PA100017.
Повний текст джерелаMarket allocation resources in health economics is amended by incorporating institutional factors as contracts through incentive theory. However, the institutionakl framework cannot be reduced to a set of contracts between parties. The existence of cognitive rules (such as professional ethics) is an important factor of stability and efficiency of the relation between parties. The behaviour of parties is based on "activity conventions" explaining the form of the service supplied by the physician, in the framework of gift-exchange, and on "quality conventions" which guarantee the quality of this service. Main health economics politicy principles are displayed following the analysis of those conventions
Книги з теми "Économie de la santé – Cancer – France"
Carnet de santé de la France 2006: Économie, droit et politiques de santé. Paris: Mutualité française / Dunod, 2006.
Знайти повний текст джерелаCrott, Ralph, Iftekhar Khan, and Zahid Bashir. Economic Evaluation of Cancer Drugs. Taylor & Francis Group, 2021.
Знайти повний текст джерелаEconomic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data. Taylor & Francis Group, 2019.
Знайти повний текст джерелаCrott, Ralph, Iftekhar Khan, and Zahid Bashir. Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data. Taylor & Francis Group, 2019.
Знайти повний текст джерелаCrott, Ralph, Iftekhar Khan, and Zahid Bashir. Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data. Taylor & Francis Group, 2019.
Знайти повний текст джерелаCrott, Ralph, Iftekhar Khan, and Zahid Bashir. Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data. Taylor & Francis Group, 2019.
Знайти повний текст джерелаCrott, Ralph, Iftekhar Khan, and Zahid Bashir. Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data. Taylor & Francis Group, 2019.
Знайти повний текст джерелаЧастини книг з теми "Économie de la santé – Cancer – France"
Estève, J. "Incidence et mortalité du cancer du sein en France. Quelle relation avec le dépistage?" In Le dépistage du cancer du sein: un enjeu de santé publique, 41–51. Paris: Springer Paris, 2007. http://dx.doi.org/10.1007/978-2-287-39695-3_2.
Повний текст джерелаGarraud, Clotilde, Florence Sordes, Aurélie Croiset, and Laury Beaubrun. "La qualité de vie sexuelle des patientes atteintes de cancer du sein." In Pratiques et interventions en psychologie de la santé, 93–104. Editions des archives contemporaines, 2020. http://dx.doi.org/10.17184/eac.3188.
Повний текст джерелаJunod, Bernard, and Christine Quélier. "11. Les valeurs sopposent-elles aux normes dans la pratique actuelle de la chirurgie du cancer du sein en France ?" In Normes et valeurs dans le champ de la santé, 165. Presses de lEHESP, 2004. http://dx.doi.org/10.3917/ehesp.cress.2004.01.0165.
Повний текст джерелаALLIO, I., A. M. DEMARTINI, J. J. MENEC, V. CARDE, and V. TREGUER-HERROU. "Le dépistage par le Laboratoire d’analyses, de surveillance et d’expertise de la Marine de Brest du radon, un gaz radioactif naturel en Bretagne." In Médecine et Armées Vol. 44 No.4, 309–16. Editions des archives contemporaines, 2016. http://dx.doi.org/10.17184/eac.6820.
Повний текст джерела